PDB15 A COST-EFFECTIVENESS ANALYSIS OF SWITCHING TYPE-2 DIABETES PATIENTS FROM IMMEDIATE-RELEASE METFORMIN (GLUCOPHAGE®) TO A NEW EXTENDEDRELEASE FORMULATION OF METFORMIN (GLUCOPHAGE®XR)
- 作者C Renaudin; S Roze; WJ Valentine; AJ Palmer
- 卷第7卷
- 期第6期
- 文件大小64.63KB
- 发表时间2004
- DOI10.1016/s1098-3015(10)65958-x
同作者推荐
Tracking pacemaker and implantable cardioverter defibrillator utilization rates in Europe 2008–2012Banks, H; Fattore, G; Torbica, A; Valzania, C; Boriani, G; Hunger, T; Varabyova, Y; Rupel, V Prevolnik; Slabe-Erker, R; Arvandi, M; Jhuti, G · European Journal of Public Health · 2015
PRS3 COST ANALYSIS OF FOURTREATMENT STRATEGIES IN THE MANAGEMENT OF MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN APPLICATION ON NON-PARAMETRIC BOOTSTRAPG Fattore; A Torbica; M Mangone · 2005